medigraphic.com
ISSN 1726-6718 (Electronic)
Revista Cubana de Anestesiología y Reanimación

2015, Number 2

<< Back Next >>

Revista Cubana de Anestesiología y Reanimación 2015; 14 (2)

Criteria for the administration of red blood cells of patients receiving surgical treatment

Alemán RS, Abad HRM, Pérez MG

Language: Spanish
References: 46
Page: 124-135
PDF size: 128.03 Kb.


ABSTRACT

Introduction: most transfusions are given in surgery patients (60 to 70 %) and anesthesiologists are responsible for the indication of the majority (50 to 60 %). Adequate transfusion practice requires constant and critical clinical assessment, taking into account that allogeneic blood transfusion is risky.
Objective: evaluating the indication criteria of red cells in patients undergoing surgery.
Methods: an observational, descriptive, cross-sectional study in the Department of Anesthesiology Hermanos Ameijeiras Clinical Surgical Hospital was performed.
Results: predominant age group of 60 and over (49 %), women 64 % overweights and 44 %. 22 % had a history of hypertension. In 67 % of cases it was not expressed in the history of transfusion criteria.
Conclusions: no patient in the valid precise indication of blood transfusion criteria was used.


REFERENCES

  1. Brevig J, McDonald J, Zelinka ES, et al. Blood transfusión reduction in cardiac surgery: multidisciplinary approach at a community hospital. Ann Thorac Surg. 2009;87:532-9.

  2. Reddy SM, Talwar S, Velayoudam D, et al. Multi-modality blood conservation strategy in open-heart surgery: an audit. Interact Cardiovasc Thorac Surg. 2010;9:480-2.

  3. Goodnough LT, Shander A. Blood management. Arch Pathol Lab Med. 2011;131:695-701.

  4. The McDonnell Norms Group. Enhancing the use of clinical guidelines: a social norms perspective. J Am Coll Surg. 2006;202:826-36.

  5. Vlaar AP, In der Maur AL, Binnekade JM, Schultz MJ, Juffermans NP. Determinants of transfusion decisions in a mixed medical-surgical intensive care unit: a prospective cohort study. BloodTransfus. 2009;7:106-10.

  6. Gombotz H, Rehak PH, Shander A, Hofmann A. Blood use in elective surgery: the Austrian benchmark study. Transfusion. 2011;47:1468-80.

  7. Departament of Health and Human Services. (US). The 2009 national blood collection and utilization survey report. Washington (DC): Departament of Health and Human Services, Office of the Assistant Secretary of Health; 2011.

  8. Vargas MC. Uso de hemocomponentes en la práctica médica e implicaciones legales. Med Leg Costa Rica [serial online]. 2011 Sep. [citado 3 Oct. 2012];28(2):[11 pantallas]. Disponible en: URL: http://www.scielo.sa.cr/scielo.php?pid=S1409 00152011000200005&script=sci_arttext&tlng=pt

  9. Leal R, Alberca I, Asuero S, Bóveda JL, Carpio N, Contreras E. Documento "Sevilla" de Consenso sobre alternativas a la Transfusión de Sangre Alogénica. Med Clin (Barc). 2010;27(1):3-20.

  10. Surgenor SD, Wall MH. Changing Concepts of Transfusions Triggers: Lessons from the ICU. ASA Newsletter. 2011;70(4):1-8.

  11. Organización Panamericana de la Salud. Estándares de Trabajo para Servicios de Sangre, Políticas y Regulaciones. Washington DC. 2005.

  12. Organización Mundial de la Salud. El uso clínico de la sangre. Manual de bolsillo. Ginebra. OMS; 2011.

  13. Jackson JN, Snowden CA, Indrikovs AJ. A prospective audit program to determine blood component transfusions appropriateness at a large university hospital: A 5 year experience. Transfusion Medicine Reviews. 2011;22(2):154-61.

  14. Vuille LE, Boudreault D, Girard F, Ruel M, Chagnon M, Hardy JF. Transfusión de glóbulos rojos en la práctica de la cirugía electiva: un estudio de cohorte multicéntrico. Transfusión. 2010;50(10):2117-24.

  15. Hidalgo Menéndez PA. Efectos de la hemodilución normovolémica con autodonación de bajo volumen sobre varios parámetros hematológicos en la cirugía cardiovascular con circulación extracorpórea. Corsalud. 2011 [citado 8 Nov. 2012];3(3). Disponible en: http://www.corsalud.sld.cu/sumario/2011/v3n3a11/efectos.htm

  16. Juárez RE, Jezabel MA, Marín VC, López R, et al. Auditoría transfusional retrospectiva en el Centro Nacional de la Transfusión Sanguínea. Rev Invest Clín. 2013;56:38-42.

  17. Bennett-Guerrero E, Zhao Y, O´Brien SM, Ferguson TB, Peterson ED, Gammie JS, et al. Variation in use of blood transfusión in coranary artery bypasses graft surgery. JAMA. 2010;304:1568-75.

  18. Rodríguez MH. Indicaciones para transfusión de Eritrocitos: concentración de la hemoglobina y características de la anemia: Rev Med IMSS. 2010;42(2):145-54.

  19. Roseft SD. Guideline for Transfusion: A way to decrease transfusion. TATM. 2010;6(2):27-36.

  20. Sadaka F, Aggu-SR, Krause K, O´Brien J, Ambrecht ES, Taylor RW. The effect of red blood cell transfusion on tissue oxygenation and microcirculation in severe septicpatients. Ann Intensive Care. 2011;8(1):46.

  21. Gómez BR, Alfonso FD, Dita SL, Núñez AL. Guía de práctica clínica para la transfusión a pacientes en estado crítico. Medisur [serial online]. 2009 [citado 8 Nov. 2012];7(1):[10 pantallas]. Disponible en: URL: http://redalyc.uaemex.mx/src/inicio/ArtPdfRed.jsp?iCve=180020082007

  22. Marik PE, Corwin HL. Efficacy of red blood cell transfusion in the critically ill: A systematic review to the literature. Crit Care Med. 2010 Sep. 36(9):2667-74.

  23. Napolitano LM, Kurek S, Luchette FA, Corwin HL, Barie PS, Tisherman SA, et al. Clinical practice guideline: Red blood cell, transfusion in adult trauma and critical care. Crit Care Med. 2009;37(12):3124-57.

  24. Middelburg R, Van de Watering L, Van der Bom J. Blood transfusions: good or bad? Transfusion. 2010;50(6):1181-3.

  25. Díaz RA. Criterios usados para instaurar transfusiones de componentes sanguíneos. Hospital Escuela "Dr. Roberto Calderón Gutiérrez" de Managua, Nicaragua, durante el período de enero de 2012 a enero de 2013.

  26. García C MC. Ética y calidad en los servicios de sangre. Acta Bioeth. 2011;17(1):55-9.

  27. Sanzama K. The ethics of blood management. Vox Sanguinis. 2010;92(2):103-12.

  28. Ferraris VA, Brown JR, Despotis GJ, Hammon JW, Reece TB, Saha SP, et al. 2011 Update to The Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists Blood Conservation Clinical Practice Guidelines. Ann Thorac Surg. 2011 Mar;91(3):944-82. doi: 10.1016/j.athoracsur.2010.11.078.

  29. Almuslim O, Leasa B. Best evidence in critical care medicine: The use of recombinant human erythropoietin to reduce red cell transfusions in critically ill patients. Can J Anesth. 2010;51:621-2.

  30. Weiskopf RB, Viele MK, Feiner J, Kelley S, Lieberman J, Noorani M, et al. Human cardiovascular and metabolic response to acute, severe isovolemic anemia. JAMA. 2008;279:217-21.

  31. Hebert PC, QunHu L, Biro GP. Review of physiologic mechanisms in response to anemia. Can Med Assoc. J 2012;156(Suppl 11):S27-40.

  32. Weiskopf RB. Do we know when to transfuse red cells to treat acute anemia? Transfusion. 1998:38:517-21.

  33. Babineau TJ, Dzik WH, Borlase BC, et al. Reevaluation of current transfusion practices in patients in surgical intensive care units. Am J Surg. 2012;164:22-5.

  34. Shoemaker WC, Appel PL, Kram HB. Role of oxygen debt in the development of organ failure sepsis, and death in high-risk surgical patients. Chest. 2012;102(1):208-15.

  35. Alia I, Esteban A, Gordo F, Lorente JA, Diaz C, Rodriguez JA, et al. A randomized and controlled trial of the effect of treatment aimed at maximizing oxygen delivery in patients with severe sepsis or septic shock. Chest. 1999 Feb;115(2):453-61.

  36. Gattinoni L, Brazzi L, Pelosi P, Latini R, Tognoni G, Pesenti A, et al. A trial of goal-oriented hemodynamic therapy in critically ill patients. SvO2 Collaborative Group. N Engl J Med. 2010;333(16):1025-32.

  37. Heyland DK, Cook DJ, King D, Kernerman P, Brun-Buisson C. Maximizing oxygen delivery in critically ill patients: a methodological appraisal of the evidence. Crit Care Med. 2010;24(3):517-24.

  38. Valeri CR, Crowley JP, Loscalzo J. The red cell transfusions trigger: has a sin of commission now become a sin of omission? Transfusion. 2010;38:602-7.

  39. McFarland JG. Perioperative Blood. Transfusions Indications and Options Chest. 2009;115:113S-121S.

  40. Nelson AH, Fleisher LA, Rosenbaum SH. Relationship between postoperative anemia and cardiac morbidity in high-risk vascular patients in the intensive care unit. Crit Care Med. 2013;21(6):860-6.

  41. Henling CE, Carmichael MF, Keats AS, et al. Cardiac operation for congenital heart disease in children of Jehovah‟s Witnesses. J Thorac Cardiovasc Surg. 2008;89(6):914-20.

  42. Rosengart TK, Helm RE, DeBois WJ, et al. Open heart operations without transfusion using a multimodality blood conservation strategy in 50 Jehovah‟s Witness patients: implications for a "bloodless" surgical technique. J Am CollSurg. 2011;184(6):618-29.

  43. Hebert PC, Wells G, Marshall J, et al, for the Canadian Critical Care Trials Group. Transfusion requirements in critical care: a pilot study [erratum appears in JAMA 1995;274(12):944]. JAMA. 2005;273:1439-44.

  44. Hébert PC, Wells G, Tweeddale M, Martin C, Marshall J, Pham B, et al. Does transfusion practice affect mortality in critically ill patients? Am J Respir Crit Care Med. 1997;155:1618-23.

  45. Trials Group. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med. 2009;340:409-17.

  46. Carson JL, Hill S, Carless P, et al. Transfusion triggers: a systematic review of the literature. Transfus Med Rev. 2002;16:187-99.




2020     |     www.medigraphic.com